The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Children's National Medical Center
111 Michigan Avenue, NW
Washington, DC 20010
The Urea Cycle Disorders Consortium (UCDC) is a team of doctors, researchers, and patient advocates throughout the US, working together to improve the lives of individuals and families affected by urea cycle disorders through research and education. The consortium provides a way for patients to join doctors and researchers in developing new and better treatments for urea cycle disorders by participating in research studies. The greater the collaboration between doctors and patients, the more that can be learned about urea cycle disorders. This important first step is necessary in order to find new and better treatments. The goals of the UCDC are to: develop better treatments and a deeper scientific understanding of the causes of UCD; understand how UCDs can cause brain damage and develop protection against this; conduct clinical trials of promising new drugs for the treatment of UCD; work with the National Urea Cycle Disorders Foundation, the UCD patient advocacy group, to help patients who wish to be involved in research connect with doctors conducting UCD research; construct and maintain resources with significant information for clinicians, researchers, and patients; train physicians to become experts in providing care for and treating those with UCD.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.